She studies the clinical impact of the herpes virus on immuno-suppressed patients. More specifically, her research explores the consequences of reactivation or infection with herpes viruses (especially CMV and EBV) in organ transplants recipients. She is trying to find ways to minimize the impact of these viruses on morbidity, mortality and graft survival.